Meet Inspiring Speakers and Experts at our 3000+ Global Conference Series LLC LTD Events with over 1000+ Conferences, 1000+ Symposiums
and 1000+ Workshops on Medical, Pharma, Engineering, Science, Technology and Business.

Explore and learn more about Conference Series LLC LTD : World’s leading Event Organizer


6th World Congress and Expo on Applied Microbiology

Rome, Italy

Ali O Kilic

Ali O Kilic

Karadeniz Technical University, Turkey

Title: Antibacterial properties of three newly identified recombinant Staphylococcus aureus phage endolysins


Biography: Ali O Kilic


Staphylococcus aureus causes serious infections in humans and animals. Controlling of staphylococcal infections is becoming very difficult to due to the emergence of multidrug-resistant strains. Therefore, search for novel antimicrobial alternatives has become of great importance. One of these new approaches is bacteriophage-encoded endolysin enzymes, which have exogenous lytic activity against multiple antibiotic resistant bacteria, especially in Gram positive bacteria. In this study, we described cloning, expression and functional analysis of three endolysins from temperate bacteriophages from three clinical isolates of S. aureus strains. Temperate phages were isolated from the host strains using the mitomycin C induction. The endolysin genes of the phages were amplified using PCR, cloned and over-expressed in E.coli. The lytic activity of endolysins were tested against a wide range of bacterial species using spot-on-lawn assay method. The combination of the three endolysins (LysSA10, LysSA14 and LysSA15) displayed activity against 222 of 239 (93%) of S. aureus strains including 67 MRSA and 6 ATCC type strains. In addition, endolysins showed lytic activity against other Gram positive bacteria including a number of clinical and type strains of S. epidermidis, S. haemolyticus, Enterococcus faecalis, E. faecium, Streptococcus pyogenes, S. pneumoniae, S. intermedius, Bacillus subtilis, and B. atrophaeus.  No lytic activity was observed against 7 Lactobacillus and one Listeria monocytogenes ATCC type strains tested.Overall, our results showed that the combination of the newly identified three recombinant endolysins exhibited a broad host range against several Gram positive bacteria. Thus, these endolysins are promising antimicrobial agents for combating bacterial pathogens.